CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages

被引:226
作者
Gleissner, Christian A. [1 ,2 ]
Shaked, Iftach [1 ]
Little, Kristina M. [1 ]
Ley, Klaus [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA
[2] Heidelberg Univ, Dept Cardiol, D-6900 Heidelberg, Germany
基金
美国国家卫生研究院;
关键词
PLATELET-FACTOR-4; PF4; PLATELET CHEMOKINES; FOAM CELLS; ATHEROSCLEROSIS; ACTIVATION; EXPRESSION; DIFFERENTIATION; HETEROGENEITY; ATHEROGENESIS; PHENOTYPE;
D O I
10.4049/jimmunol.0901368
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In atherosclerotic arteries, blood monocytes differentiate to macrophages in the presence of growth factors, such as macrophage colony-stimulation factor (M-CSF), and chemokines, such as platelet factor 4 (CXCL4). To compare the gene expression signature of CXCL4-induced macrophages with M-CSF-induced macrophages or macrophages polarized with IFN-gamma/LPS (M1) or IL-4 (M2), we cultured primary human peripheral blood monocytes for 6 d. mRNA expression was measured by Affymetrix gene chips, and differences were analyzed by local pooled error test, profile of complex functionality, and gene set enrichment analysis. Three hundred seventy-five genes were differentially expressed between M-CSF- and CXCL4-induced macrophages; 206 of them over-expressed in CXCL4 macrophages coding for genes implicated in the inflammatory/immune response, Ag processing and presentation, and lipid metabolism. CXCL4-induced macrophages overexpressed some M1 and M2 genes and the corresponding cytokines at the protein level; however, their transcriptome clustered with neither M1 nor M2 transcriptomes. They almost completely lost the ability to phagocytose zymosan beads. Genes linked to atherosclerosis were not consistently upregulated or downregulated. Scavenger receptors showed lower and cholesterol efflux transporters showed higher expression in CXCL4- than M-CSF-induced macrophages, resulting in lower low-density lipoprotein content. We conclude that CXCL4 induces a unique macrophage transcriptome distinct from known macrophage types, defining a new macrophage differentiation that we propose to call M4. The Journal of Immunology, 2010, 184: 4810-4818.
引用
收藏
页码:4810 / 4818
页数:9
相关论文
共 35 条
[1]   ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data [J].
Antonov, Alexey V. ;
Schmidt, Thorsten ;
Wang, Yu ;
Mewes, Hans W. .
NUCLEIC ACIDS RESEARCH, 2008, 36 :W347-W351
[2]  
Bengtsson E, 2008, FRONT BIOSCI, V13, P5780
[3]   PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties [J].
Bouhlel, M. Amine ;
Derudas, Bruno ;
Rigamonti, Elena ;
Dievart, Rebecca ;
Brozek, John ;
Haulon, Stephan ;
Zawadzki, Christophe ;
Jude, Brigitte ;
Torpier, Gerard ;
Marx, Nikolaus ;
Staels, Bart ;
Chinetti-Gbaguidi, Giulia .
CELL METABOLISM, 2007, 6 (02) :137-143
[4]   Coronary Intraplaque Hemorrhage Evokes a Novel Atheroprotective Macrophage Phenotype [J].
Boyle, Joseph J. ;
Harrington, Heather A. ;
Piper, Emma ;
Elderfield, Kay ;
Stark, Jaroslav ;
Landis, Robert C. ;
Haskard, Dorian O. .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (03) :1097-1108
[5]   Induction of dendritic cell-like phenotype in macrophages during foam cell formation [J].
Cho, Hyung Jun ;
Shashkin, Pavel ;
Gleissner, Christian A. ;
Dunson, Dane ;
Jain, Nitin ;
Lee, Jae K. ;
Miller, Yury ;
Ley, Klaus .
PHYSIOLOGICAL GENOMICS, 2007, 29 (02) :149-160
[6]   Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (Op) and apolipoprotein E [J].
de Villiers, WJS ;
Smith, JD ;
Miyata, M ;
Dansky, HM ;
Darley, E ;
Gordon, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :631-640
[7]   Immune and Inflammatory Mechanisms of Atherosclerosis [J].
Galkina, Elena ;
Ley, Klaus .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :165-197
[8]  
GERRITY RG, 1981, AM J PATHOL, V103, P191
[9]  
GERRITY RG, 1981, AM J PATHOL, V103, P181
[10]   INHIBITION OF HUMAN MEGAKARYOCYTOPOIESIS INVITRO BY PLATELET FACTOR-4 (PF4) AND A SYNTHETIC COOH-TERMINAL PF4 PEPTIDE [J].
GEWIRTZ, AM ;
CALABRETTA, B ;
RUCINSKI, B ;
NIEWIAROWSKI, S ;
XU, WY .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1477-1486